VivoSeq
Other

Menopausal Women

0

Pipeline Programs

8

Active Trials

18

Companies Involved

Menopausal Women is an early-stage landscape with 0 programs across 18 companies. The most active players are Sprout Pharmaceuticals, Inc, Novartis, Eli Lilly.

Pipeline Metrics

Competitive Density

24/100

Pipeline Velocity

11/100

Mech. Concentration

N/A

Completion Rate

91/100

Attrition Rate

7/100

Competitive Landscape

Bubble size = clinical trials

Approved
Phase 3
Phase 2
Phase 1
Preclinical

Programs by Phase

No pipeline programs currently tracked for this disease.

Trial Status

87

clinical trials

Completed59 · 68%
Unknown status14 · 16%
Terminated5 · 6%
Not yet recruiting4 · 5%
Active, not recruiting2 · 2%
Recruiting2 · 2%
Other1 · 1%

Trial Activity

87 trials

PTH Comparison in Post Menopausal Women
Completed·Eli Lilly logoEli Lilly·Phase 3·NCT00543218·63 enrolled
Study of Paxil Use in Menopausal Women
Completed·MMassachusetts General Hospital·Phase 4·NCT00225914·64 enrolled
Page 1 of 6

Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)